
As a new COVID-19 strain emerges in the southeast of England that appears to be more infectious than previous strains, what do…
As a new COVID-19 strain emerges in the southeast of England that appears to be more infectious than previous strains, what do…
Discover the vast impacts of the COVID-19 pandemic on the lab research community: from funding cuts, to PhD students changing…
Pfizer and BioNTech’s COVID-19 vaccine has been approved for use by the UK’s regulator, MHRA, making it the first COVID-19…
While the latest set of interim vaccine results from Oxford University and AstraZeneca include an efficacy score of 70%, significantly…
World Antimicrobial Awareness Week 2020 (WAAW; 18–24 November) is upon us. Infectious Diseases Hub takes a look at the past,…
Just 1 week after Pfizer and BioNTech’s early Phase III trial data were released, more good news comes from Moderna’s…
The first set of data from Pfizer (NY, USA) and BioNTech’s (Mainz, Germany) Phase III clinical trial for their COVID-19…
Wednesday 18 November 2020 11:00 [EST] 08:00 [PST] 16:00 [GMT] Alternative time zones REGISTER NOW The pharmaceutical industry is in…
Three blood metabolites have been identified by Canadian researchers that appear to be affected by COVID-19, which could be measured in…
The question of COVID-19 immunity is on everyone’s lips. It is crucial to understand how immunity develops post-exposure to the virus…